1. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. (November 2019) Authors: Joharatnam-Hogan, Nalinie; Cafferty, Fay; Hubner, Richard; Swinson, Daniel; Sothi, Sharmila; Gupta, Kamalnayan; Falk, Stephen; Patel, Kinnari; Warner, Nicola; Kunene, Victoria; Rowley, Sam; Khabra, Komel; Underwood, Tim; Jankowski, Janusz; Bridgewater, John; Crossley, Anne; Henson, Verity; Berkma... Journal: Lancet gastroenterology and hepatology Issue: Volume 4:Number 11(2019) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Issue 5 (May 2019) Authors: Primrose, John N; Fox, Richard P; Palmer, Daniel H; Malik, Hassan Z; Prasad, Raj; Mirza, Darius; Anthony, Alan; Corrie, Pippa; Falk, Stephen; Finch-Jones, Meg; Wasan, Harpreet; Ross, Paul; Wall, Lucy; Wadsley, Jonathan; Evans, Jeff T R; Stocken, Deborah; Praseedom, Raaj; Ma, Yuk Ting; Davidson, B... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial. Issue 33 (20th November 2021) Authors: Adams, Richard A.; Fisher, David J.; Graham, Janet; Seligmann, Jenny F.; Seymour, Matthew; Kaplan, Richard; Yates, Emma; Parmar, Mahesh; Richman, Susan D.; Quirke, Philip; Butler, Rachel; Brown, Ewan; Collinson, Fiona; Falk, Stephen; Wasan, Harpreet; Shiu, Kai-Keen; Middleton, Gary; Samuel, Lesli... Journal: Journal of clinical oncology Issue: Volume 39:Issue 33(2021) Page Start: 3693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Issue 10073 (11th March 2017) Authors: Neoptolemos, John P; Palmer, Daniel H; Ghaneh, Paula; Psarelli, Eftychia E; Valle, Juan W; Halloran, Christopher M; Faluyi, Olusola; O'Reilly, Derek A; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Anthoney, Alan; Lind, Pehr; Glimelius, Bengt; Falk, Stephe... Journal: Lancet Issue: Volume 389:Issue 10073(2017) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma. (January 2020) Authors: Thomas, Anne; Virdee, Pradeep S.; Eatock, Martin; Lord, Simon R.; Falk, Stephen; Anthoney, D. Alan; Turkington, Richard C.; Goff, Matthew; Elhussein, Leena; Collins, Linda; Love, Sharon; Moschandreas, Joanna; Middleton, Mark R. Journal: European journal of cancer Issue: Volume 124(2020) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Issue 9 (September 2017) Authors: Adams, Richard; Bateman, Andrew; Blesing, Claire; Brown, Ewan; Chau, Ian; Cummins, Sebastian; Cunningham, David; Falk, Stephen; Hadaki, Maher; Hall, Marcia; Hickish, Tamas; Hornbuckle, Joanne; Lofts, Fiona; Lowndes, Sarah; Mayer, Astrid; Metcalfe, Matthew; Middleton, Gary; Mills, Jamie; Montazeri... Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Issue 9 (September 2017) Authors: Adams, Richard; Bateman, Andrew; Blesing, Claire; Brown, Ewan; Chau, Ian; Cummins, Sebastian; Cunningham, David; Falk, Stephen; Hadaki, Maher; Hall, Marcia; Hickish, Tamas; Hornbuckle, Joanne; Lofts, Fiona; Lowndes, Sarah; Mayer, Astrid; Metcalfe, Matthew; Middleton, Gary; Mills, Jamie; Montazeri... Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial. (March 2018) Authors: Adams, Richard; Brown, Ewan; Brown, Louise; Butler, Rachel; Falk, Stephen; Fisher, David; Kaplan, Richard; Quirke, Phil; Richman, Susan; Samuel, Leslie; Seligmann, Jenny; Seymour, Matt; Shiu, Kai Keen; Wasan, Harpreet; Wilson, Richard; Maughan, Tim Journal: Lancet gastroenterology and hepatology Issue: Volume 3:Number 3(2018) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Issue 18 (20th June 2022) Authors: Bridgewater, John; Fletcher, Peter; Palmer, Daniel H.; Malik, Hassan Z.; Prasad, Raj; Mirza, Darius; Anthony, Alan; Corrie, Pippa; Falk, Stephen; Finch-Jones, Meg; Wasan, Harpreet; Ross, Paul; Wall, Lucy; Wadsley, Jonathan; Evans, Thomas R.; Stocken, Deborah; Stubbs, Clive; Praseedom, Raaj; Ma, Y... Journal: Journal of clinical oncology Issue: Volume 40:Issue 18(2022) Page Start: 2048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. Issue 9 (September 2017) Authors: Alderson, Derek; Cunningham, David; Nankivell, Matthew; Blazeby, Jane M; Griffin, S Michael; Crellin, Adrian; Grabsch, Heike I; Langer, Rupert; Pritchard, Susan; Okines, Alicia; Krysztopik, Richard; Coxon, Fareeda; Thompson, Joyce; Falk, Stephen; Robb, Clare; Stenning, Sally; Langley, Ruth E Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗